Reactivity of new adhesion molecules on lymphocytes from patients with chronic graft versus host disease

Acta Microbiologica et Immunologica Hungarica

Volumn 50, Issue 1, 2003, Pages 55-65

  Regéczy, Nóra ^a,c   Kormos, Luca ^a,b   Szigetvári, Csilla M ^a   Torbágyi, Éva ^a   Hajdu, Melinda ^a   Gopcsa, L ^a   Bányai, Anikó ^a   Pálóczi, Katalin ^a,b  

^a NATIONAL MEDICAL CENTER   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Adhesion molecule; Allogeneic transplantation; Chronic GVHD

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; ADAM PROTEIN; ADAM8 PROTEIN, HUMAN; HERMES ANTIGEN; HYALURONAN MEDIATED MOTILITY RECEPTOR; HYALURONAN-MEDIATED MOTILITY RECEPTOR; LEUKOCYTE ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; MEMBRANE PROTEIN; METALLOPROTEINASE; SCLEROPROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CHRONIC DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LYMPHOCYTE; MALE; POPULATION RESEARCH; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; ALLOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED; T LYMPHOCYTE SUBPOPULATION;

ADAM PROTEINS; ADULT; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD44; ANTIGENS, CD8; CHRONIC DISEASE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOPHENOTYPING; MALE; MEMBRANE PROTEINS; METALLOENDOPEPTIDASES; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037901903     PISSN: 12178950     EISSN: None     Source Type: Journal    
DOI: 10.1556/AMicr.50.2003.1.6     Document Type: Article

References (22)

1. Wilson, J.G., Adhesive interactions in hemopoiesis. Acta Haematol. 97, 6 (1997).
2. Westerman, J., Bode, U., Distribution of activated T cells migrating through the body: a matter of life and death. Immunology Today 20, 302 (1999).
3. Pálóczi K., Immune reconstitution: an important component of a successful allogeneic transplantation. Immunology Letters 74, 177 (2000).
4. Sherer, Y., Shoenfeld, Y., Autoimmune diseases and autoimmunity post-bone marrow transplantation. Bone Marrow Transplant. 22, 873 (1998).
5. Kelemen, E., Masszi, T., Reményi, P., Barta, A., Pálóczi, K., Reduction in the frequency of transplant-related complications in patients with chronic myeloid leukemia undergoing BMT preconditioned with a new, non-myeloablative drug combination. Bone Marrow Transplant. 22, 747 (1998).
6. Sullivan, K.M., Chronic graft versus host disease and other late complication of bone marrow transplantation. Semin. Haematol. 28, 250 (1991).
7. Parkman, R., Is chronic graft versus host disease an autoimmune disease? Curr. Op. Immunol. 5, 800 (1993).
8. Norton, J., Al-Saffar, N., Sloane, J.P., Adhesion molecule expression in human hepatic graft versus host disease. Bone Marrow Transplant. 10, 153 (1992).
9. Pálóczi, K., Poros, A., Szelényi, J., Hollán, S.R., Petrányi, G., TCR gamma/delta bearing lymphocytes in peripheral blood of allogeneic bone marrow transplanted patients. Leukemia 6 (S3), 98 (1992).
10. Pálóczi, K., Barta, A., Gopcsa, L., Ézsi, R., Petrányi G.Gy: Immunophenotypic characterisation of cord blood B-lymphocytes. Bone Marrow Transplant. 22 (S4), 89 (1998).
11. Kormos, L., Regéczy, N., Pálóczi, K., Reactivity of peripheral blood lymphocytes in patients with chronic graft versus host disease with the Workshop unclustered adhesion panel antibodies. Tissue Antigens 55 (S1), 8 (2000).
12. Black, R.A., A metalloproteinase disintegrin that releases tumour necrosis factor alpha from cells. Nature 385, 729 (1997).
13. Alves, F., Vogel, W., Mossie, K. et al. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression inhuman cancer. Oncogene 10, 609 (1995).
14. Gares, S.L., Pilarski, L.M., During human thymic development, beta 1 integrins regulate adhesion, motility, and the outcome of RHAMM/hyaluronan engagement. J. Leukoc. Biol. 64, 781 (1998).
15. Pilarski, L.M., Turley, E. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells. J. Immunol. 150, 4292 (1993).
16. Gares, S.L., Pilarski, L.M., PROW guides on new CD Candidates and CD Antigens in conjuction with the 7th Workshop and Conference on HLDA. Harrogate, UK, p11 (2000).
17. Moos, M., Schanner, M., Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature 334, 701 (1988).
18. Di Sciullo, G., Bogen, S.A., L1 antibodies block lymph node fibroblastic reticular matrix remodelling in vivo. J. Exp. Med. 187(12), 1953 (1998).
19. Balaian, L.B., Montgomery, A.M., The human neural cell adhesion molecule L1 functions as a costimulatory molecule in T cell activation. E.J.I. 30(3), 938 (2000).
20. Hortsch, M., The L1 family of neural cell adhesion molecules: old proteins performing new tricks. NEURO 17, 587 (1996).
21. Pancook, J.D., Montgomery, A.M., Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin. J. Immunol. 158, 4413 (1997).
22. Schlegel, P.G., The role of adhesion and costimulatory molecule in graft-versus-host disease. Acta. Haematol. 97, 105 (1997).